Alexin Ophthalmics Private Limited
Medical and orthopedic goods trading since 2014 in Uttar Pradesh.
2014 | Lucknow, Uttar Pradesh (India) | Active
Alexin Ophthalmics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 2.79%
- Profit Growth 3.22%
- Ebitda 22.30%
- Net Worth 12.81%
- Total Assets 12.14%
About Alexin Ophthalmics
Alexin Ophthalmics Private Limited (AOPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 December 2014 and has a history of Ten years and two months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ruby Srivastava and Mahesh Srivastava serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233UP2014PTC067808
- Company No.
067808
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Healthcare
Who are the key members and board of directors at Alexin Ophthalmics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ruby Srivastava  | Director | 24-Dec-2014 | Current |
| Mahesh Srivastava | Director | 24-Dec-2014 | Current |
Financial Performance of Alexin Ophthalmics.
Alexin Ophthalmics Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.79% increase. The company also saw a slight improvement in profitability, with a 3.22% increase in profit. The company's net worth Soared by an impressive increase of 12.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alexin Ophthalmics?
In 2022, Alexin Ophthalmics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alexin Ophthalmics?
Unlock and access historical data on people associated with Alexin Ophthalmics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alexin Ophthalmics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alexin Ophthalmics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.